NanoVibronix Inc (NAOV) USD0.001

Sell:$5.20Buy:$5.76$0.75 (12.71%)

Prices delayed by at least 15 minutes
Sell:$5.20
Buy:$5.76
Change:$0.75 (12.71%)
Prices delayed by at least 15 minutes
Sell:$5.20
Buy:$5.76
Change:$0.75 (12.71%)
Prices delayed by at least 15 minutes

Company Information

About this company

NanoVibronix, Inc. is a medical device company focused on developing medical devices utilizing its patented low intensity surface acoustic wave (SAW) technology. The technology allows for the creation of low-frequency ultrasound waves that can be utilized for a variety of medical applications, including for disruption of biofilms and bacterial colonization, as well as for pain relief. The Company's primary products include PainShield and UroShield, which are portable devices suitable for administration at home or in any care setting. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use.

Key people

Brian M. Murphy
Chief Executive Officer, Director
Stephen Russell Brown
Chief Financial Officer
Harold Jacob
Chief Medical Officer
Christopher M. Fashek
Independent Chairman of the Board
Doron Besser
Director
Martin S. Goldstein
Independent Director
Thomas R. Mika
Independent Director
Zeev Rotstein
Independent Director
Click to see more

Key facts

  • EPIC
    NAOV
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US63008J7028
  • Market cap
    $4.60m
  • Employees
    15
  • Shares in issue
    759,297.00
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.